HCPC
BSX icon

Hamilton Capital Partners (Canada)’s Boston Scientific BSX Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.39M Buy
126,213
+34,318
+37% +$1.86M 0.16% 132
2026
Q1 		$5.77M Buy
91,895
+35,512
+63% +$2.84M 0.19% 94
2025
Q4 		$5.38M Buy
56,383
+7,589
+16% +$744K 0.2% 94
2025
Q3 		$4.76M Buy
48,794
+1,095
+2% +$113K 0.2% 94
2025
Q2 		$5.12M Buy
47,699
+8,854
+23% +$896K 0.26% 77
2025
Q1 		$3.92M Sell
38,845
-7,730
-17% -$778K 0.25% 89
2024
Q4 		$4.16M Sell
46,575
-5,428
-10% -$478K 0.31% 62
2024
Q3 		$4.36M Sell
52,003
-15,018
-22% -$1.18M 0.38% 67
2024
Q2 		$5.16M Buy
67,021
+374
+0.6% +$27.4K 0.55% 55
2024
Q1 		$4.56M Buy
+66,647
New +$4.29M 0.55% 59

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s BSX Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Boston Scientific (BSX) stake by 37% in Q2 2026, buying an estimated $1.86M and bringing the position to 126,213 shares worth $5.39M. The position accounts for 0.16% of the portfolio, ranked #132.

Hamilton Capital Partners (Canada) first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.77M in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 126,213 shares of Boston Scientific worth $5.39M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 34,318 Boston Scientific shares in Q2 2026, an estimated $1.86M.
  • Boston Scientific made up 0.16% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #132 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Hamilton Capital Partners (Canada)'s Boston Scientific position peaked at $5.77M in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.